South Australian Medicines Evaluation Panel (SAMEP)
The South Australian Medicines Evaluation Panel (SAMEP) was established in 2011 as an expert standing committee of the South Australian Medicines Advisory Committee (SAMAC) to ensure that all public hospitals provide a consistent approach to the management of High Cost Medicines. The main role of SAMEP is to review the use of High Cost Medicines, for a list of medicines being reviewed or previously reviewed, see the High Cost Medicine reviews page.
SAMEP were the winners of the 2014 SA Health Award "Excellence in Non-clinical Services"
The role of SAMEP includes:
- Evaluating the safety, the clinical efficacy and cost-effectiveness of high cost medicines proposed for inclusion in the Statewide High Cost Medicines Formulary.
- Initiating reviews to evaluate the safety and effectiveness of high cost medicines which are not registered for use within Australia for the purpose of providing guidance to local hospital drug committees with regards to consideration of individual patient use requests.
- Making recommendations to SAMAC with regards to which high cost medicines should be made available in South Australian public hospitals and on the potential place in therapy of these medicines.
- Facilitating the monitoring of high cost medicine use in South Australian public hospitals.
SAMEP meet every two months to review high cost medicine formulary applications. Scheduled meetings for 2017 are:
- 8 February
- 12 April
- 14 June
- 11 October
- 29 November
Chaired by Associate Professor Catherine Hill, SAMEP includes specialist clinicians, pharmacists, health economists, an ethicist and a consumer representative.
See below for a full listing of members.
All enquiries regarding the High Cost Medicines policy or SAMEP should be directed to the Executive Officer to SAMEP at SAMEP@sa.gov.au.
|Name||Expertise||Organisation and position|
|Professor Catherine Hill||Chair||Staff Specialist Rheumatology Unit, The Queen Elizabeth Hospital|
|Emeritus Professor Anne Tonkin||Clinical Pharmacology, Cardiology||Clinical pharmacologist, Royal Adelaide Hospital|
|Dr Chris Pearson||Paediatrics||Staff Specialist, General Medicine, Women's and Children's Hospital|
|Dr Ganessan Kichenadasse||Oncology||Consultant, Medical Oncology, Flinders Medical Centre|
|Dr Sudarsha Selva-Nayagam||Oncology||Director Medical Oncology, Royal Adelaide Hospital|
|Dr Michael Ward||Clincial Pharmacy||Lecturer, School of Pharmacy and Medical Sciences, UniSA|
|Ms Joy Gailer||Clincial Pharmacy||Clinical Pharmacist, Repatriation General Hospital|
|Ms Kirsty Scarborough||Senior Clincial Pharmacist||Senior Pharmacist, Royal Adelaide Hospital|
|Professor Tracy Merlin||Health technology assessment/ health economics||Director, Adelaide Health Technology Assessment Group, The University of Adelaide|
|Dr Jennie Louise||Medical Ethics||Lecturer in Medical Ethics, University of Adelaide|
|Michael Cousins||Consumer advocacy||Chief Executive, Health Consumers Alliance of SA|
|Dr Damian Clark||Paediatrics, Neurology||Staff specialist, Department of Neurology, Women’s and Children’s Hospital|
|Ms Catherine Booth||Paediatric clinical pharmacy||Senior Pharmacist, Women’s and Children’s Hospital|
|Ms Anne Mussared||Consumer representative||Health Consumers Alliance of SA – Consumer Advocate|
|Ms Naomi Burgess (ex officio)||Director||Director, Medicines & Technology Policy & Programs, SA Health|
|Ms Camille Schubert||Health Economist|
|Dr Benjamin Reddi||Staff Specialist||Intensive Care Unit, Royal Adelaide Hospital|
|Dr Pravin Hissaria||Clinical Immunologist and Immunopathologist||Royal Adelaide Hospital|